1.PengSK,Cholesterol oxidation derivatves and arterial endothelialdamage.Atherosclerosis,1995,54:122
2.秦樹(shù)存，硝苯吡啶對(duì)中國(guó)小型豬實(shí)驗(yàn)性動(dòng)脈粥樣硬化的抑制作用，中華心血管病雜志，1992，20（1)：41-44
3.李俠，實(shí)驗(yàn)性動(dòng)脈粥樣硬化海撥差異的超威結(jié)構(gòu)研究，中華心血管雜志，1994，22（30：209-211
4.孫寶貴，實(shí)驗(yàn)性動(dòng)脈粥樣硬化狹窄及球襄腔內(nèi)成形術(shù)的形態(tài)學(xué)變化，中華心血管雜志，1992，20（2)：126
gydjdsj.org.cn/shiti/gydjdsj.org.cn/wsj/5.徐小平，Isradipine對(duì)動(dòng)脈粥樣硬化進(jìn)程影響的實(shí)驗(yàn)研究，中華心血管雜志，1994，22（6)：455-457
6.NomotoA.Antiatherogenic activety of FR 34235(Nilvadipine),a new potent calciumantagonist effect on cuffinduced intimal thickening of rabbit carotid arteryhAtherosderosis.1987,64:255
7.NickersonCJ.Effects of hypertention and hyperlipidemia on the myocardium and coronaryvasculature of the WHHL rabbit,Exp Mol Pathol,1992,56:174
8.RainesEW,Smooth muscle cells and the ,pathogensis of the leions of atherosclerosis,BrHeart J,1993,69(suppl):S30
9.Chamley-CampbellJ,The smooth muscle cell in culture .Physiol Rev,1976,59:1
10.江
